MODELING CARDIOVASCULAR OUTCOMES OF TREATMENT WITH EMPAGLIFLOZIN IN TYPE 2 DIABETES BASED ON HARD OUTCOMES DATA

Saved in:
Bibliographic Details
Published inValue in health Vol. 19; no. 3; p. A203
Main Authors Kansal, A, Zheng, Y, Proskorovsky, I, Krotneva, S, Kandaswamy, P, Ruffolo, A
Format Journal Article
LanguageEnglish
Published 01.05.2016
Subjects
Internal Medicine
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
DOI:10.1016/j.jval.2016.03.1299